Potentially arrhythmogenic effects of haloperidol and olanzapine on cardiac autonomic function - A preliminary study

Research output: Contribution to journalArticle

Abstract

Objective: Antipsychotic medications have been linked to instances of cardio-toxicity or unexplained sudden death. Dysfunction of the cardiac autonomic nervous system may be attributable to the adverse arrhythmic effects in schizophrenic patients taking antipsychotics. Materials and Methods: Twelve schizophrenic patients with scores for the Brief Psychiatry Rating Scale of less than 40, including nine haloperidol-treated patients and three olanzapine-treated patients, were recruited from the outpatient clinic. Each patient received comprehensive measurements of cardiac autonomic nervous function changes at two time points. The first assessment was done after discontinuing the antipsychotics and anticholinergics for more than two weeks. These patients then were prescribed the antipsychotic at the previous dosage again after this first assessment. The second assessment was performed six weeks later. Results: Our study found no statistically significant differences in QTc prolongation between the nine haloperidol-treated and the three olanzapine-treated patients. None of the variables for cardiac autonomic nervous function predicted any arrythymogenic potential of the antipsychotics in our study. Conclusions: Autonomic nervous variables do not seem to be suitable indices for arrythmogenic potential in medicated schizophrenic patients. Future studies involving larger samples are needed to confirm these results.

Original languageEnglish
Pages (from-to)193-197+247
JournalTzu Chi Medical Journal
Volume18
Issue number3
Publication statusPublished - 2006 Jun 1

Fingerprint

olanzapine
Haloperidol
Antipsychotic Agents
Autonomic Nervous System
Cholinergic Antagonists
Sudden Death
Ambulatory Care Facilities
Psychiatry

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{3d574934b97b44ad810082bc74079e0a,
title = "Potentially arrhythmogenic effects of haloperidol and olanzapine on cardiac autonomic function - A preliminary study",
abstract = "Objective: Antipsychotic medications have been linked to instances of cardio-toxicity or unexplained sudden death. Dysfunction of the cardiac autonomic nervous system may be attributable to the adverse arrhythmic effects in schizophrenic patients taking antipsychotics. Materials and Methods: Twelve schizophrenic patients with scores for the Brief Psychiatry Rating Scale of less than 40, including nine haloperidol-treated patients and three olanzapine-treated patients, were recruited from the outpatient clinic. Each patient received comprehensive measurements of cardiac autonomic nervous function changes at two time points. The first assessment was done after discontinuing the antipsychotics and anticholinergics for more than two weeks. These patients then were prescribed the antipsychotic at the previous dosage again after this first assessment. The second assessment was performed six weeks later. Results: Our study found no statistically significant differences in QTc prolongation between the nine haloperidol-treated and the three olanzapine-treated patients. None of the variables for cardiac autonomic nervous function predicted any arrythymogenic potential of the antipsychotics in our study. Conclusions: Autonomic nervous variables do not seem to be suitable indices for arrythmogenic potential in medicated schizophrenic patients. Future studies involving larger samples are needed to confirm these results.",
author = "Chen, {Kao Ching} and Yang, {Yen Kuang} and Yeh, {Tzung Lieh} and Lee, {I. Hui} and Chen, {Po See} and Lu, {Ru Band} and Liu, {Ping Yen}",
year = "2006",
month = "6",
day = "1",
language = "English",
volume = "18",
pages = "193--197+247",
journal = "Tzu Chi Medical Journal",
issn = "1016-3190",
publisher = "Elsevier (Singapore) Pte Ltd",
number = "3",

}

TY - JOUR

T1 - Potentially arrhythmogenic effects of haloperidol and olanzapine on cardiac autonomic function - A preliminary study

AU - Chen, Kao Ching

AU - Yang, Yen Kuang

AU - Yeh, Tzung Lieh

AU - Lee, I. Hui

AU - Chen, Po See

AU - Lu, Ru Band

AU - Liu, Ping Yen

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Objective: Antipsychotic medications have been linked to instances of cardio-toxicity or unexplained sudden death. Dysfunction of the cardiac autonomic nervous system may be attributable to the adverse arrhythmic effects in schizophrenic patients taking antipsychotics. Materials and Methods: Twelve schizophrenic patients with scores for the Brief Psychiatry Rating Scale of less than 40, including nine haloperidol-treated patients and three olanzapine-treated patients, were recruited from the outpatient clinic. Each patient received comprehensive measurements of cardiac autonomic nervous function changes at two time points. The first assessment was done after discontinuing the antipsychotics and anticholinergics for more than two weeks. These patients then were prescribed the antipsychotic at the previous dosage again after this first assessment. The second assessment was performed six weeks later. Results: Our study found no statistically significant differences in QTc prolongation between the nine haloperidol-treated and the three olanzapine-treated patients. None of the variables for cardiac autonomic nervous function predicted any arrythymogenic potential of the antipsychotics in our study. Conclusions: Autonomic nervous variables do not seem to be suitable indices for arrythmogenic potential in medicated schizophrenic patients. Future studies involving larger samples are needed to confirm these results.

AB - Objective: Antipsychotic medications have been linked to instances of cardio-toxicity or unexplained sudden death. Dysfunction of the cardiac autonomic nervous system may be attributable to the adverse arrhythmic effects in schizophrenic patients taking antipsychotics. Materials and Methods: Twelve schizophrenic patients with scores for the Brief Psychiatry Rating Scale of less than 40, including nine haloperidol-treated patients and three olanzapine-treated patients, were recruited from the outpatient clinic. Each patient received comprehensive measurements of cardiac autonomic nervous function changes at two time points. The first assessment was done after discontinuing the antipsychotics and anticholinergics for more than two weeks. These patients then were prescribed the antipsychotic at the previous dosage again after this first assessment. The second assessment was performed six weeks later. Results: Our study found no statistically significant differences in QTc prolongation between the nine haloperidol-treated and the three olanzapine-treated patients. None of the variables for cardiac autonomic nervous function predicted any arrythymogenic potential of the antipsychotics in our study. Conclusions: Autonomic nervous variables do not seem to be suitable indices for arrythmogenic potential in medicated schizophrenic patients. Future studies involving larger samples are needed to confirm these results.

UR - http://www.scopus.com/inward/record.url?scp=33746238343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746238343&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33746238343

VL - 18

SP - 193-197+247

JO - Tzu Chi Medical Journal

JF - Tzu Chi Medical Journal

SN - 1016-3190

IS - 3

ER -